Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

480.9000 -2.15 (-0.45%)

NSE Aug 25, 2025 15:31 PM

54.13% Gain from 52W Low

Volume: 211.3K

Aarti Drugs Ltd.

20 May 2024

480.90

-0.45%

Pick of the Week:21 MAY 2024

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We recommend a BUY rating on the stock with a target price of Rs 536/share, implying an upside of 10% from CMP

Aarti Drugs Ltd. is trading below its 30 day SMA of 505.8